Digital Tissue Recognition Study Completes Enrollment.(Brief Article)

2001 DEC 27 - (NewsRx.com & NewsRx.net) -- Confirma, Inc., announced that it has completed enrollment of its breast cancer clinical study for evaluating Digital Tissue Recognition, a novel technology that analyzes magnetic resonance imaging data.

With enrollment complete, Confirma will now work with five independent radiologists to analyze Digital Tissue Recognition for its ability to assist in better determining the extent of disease in cancer patients. Digital Tissue Recognition uses a known tumor site in the individual to create a unique tumor signature to search for and identify other sites of disease, providing physicians with more information that may affect treatment and surgical planning, as well as disease management.

"Confirma's technology may play a pivotal role in changing the way staging of breast cancer is done with regard to the status of the axillary lymph nodes," said Dr. Mary K. Barnhart, a surgeon specializing in breast disease and breast cancer surgery at Rose City Breast Care in Portland, Oregon, and a referring physician in Confirma's study. "Currently, staging of the axilla still involves some type of invasive procedure, with the potential to produce lymphedema (swelling) in the patient's arm and other disabling side effects. If the Confirma study produces data to reliably predict lymph node involvement without surgical intervention, it would provide a major ...